Drug combination effective to treat patients with multiple myelomaDuring a study conducted at 44 centers in the United States and Canada and involving 353 patients with myeloma, it was found that a combination of drugs lenalidomide and dexamethasone could be useful for treating patients.

It was found during the study that pairing a new derivative of thalidomide with a steroid could slow down the progress of multiple myeloma along with prolonging lives of patients who have earlier relapsed from past treatments.

It was remarked by lead author Donna Weber, M.D., associate professor in the Department of Lymphoma and Myeloma at the University of Texas M. D. Anderson Cancer Center that these combinational drugs are effective as the disease may become immune to one therapy.